cache/de35ab3a786fb88ccc3964fd001cb4bb1bb4d6634c3aa90746abf0b9a12b91a7

CN:WZEYE

温州医科大学附属眼视光医院

  • Privately Held

Company Overview

Metric
Company Name温州医科大学附属眼视光医院Gaush Meditech Ltd苏州康捷医疗股份有限公司
Symbol2.41K
MSH IDCN:WZEYECOM:GAUSHCOM:SZKJYL
MarketPRIVATESTOCKSPRIVATE
SectorHealthcare & Health ServicesHealthcare & Health Services
IndustryMedical ServicesMedical Devices
CountryCNCNCN
Stage
Employee Count869
Websitewzeye.cngaush.comszkjyl.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap217.58M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue193.42M
Revenue (LTM)
Revenue (NTM)
Gross Profit95.13M
EBITDA50.91M
Operating Income40.46M
Net Income23.87M
EPS0.16
Diluted EPS0.16
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.49
Operating Profit Margin0.21
EBITDA Margin0.26
Net Profit Margin0.12
Return on Equity0.11
Return on Assets0.06
Return on Capital Employed0.15

Valuation Multiples

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.65
EV Multiple7.70

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding46.26
Days Inventory Outstanding218.38
Operating Cycle269.92
Cash Conversion Cycle209.72
Asset Turnover0.49

Cash Flow Metrics

Metric
Operating Cash Flow34.25M
Free Cash Flow27.98M
Cash Flow to Debt0.37
Operating Cash Flow/Sales0.18
Free Cash Flow Yield0.14

Balance Sheet Metrics

Metric
Cash & Equivalents85.10M
Accounts Receivable2.71M
Inventory45.19M
Goodwill132.24M
Debt to Capitalization0.28
Debt to Assets0.23
Current Ratio1.56
Quick Ratio1.38

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue0.04
SG&A to Revenue0.09